Sunshine Biopharma Launches Two New Generic Prescription Drugs; Varenicline, A Generic Version Of Champix; Betahistine, A Generic Version Of Serc
Portfolio Pulse from Benzinga Newsdesk
Sunshine Biopharma, Inc. (NASDAQ:SBFM) has launched two new generic drugs through its subsidiary, Nora Pharma Inc. The drugs are Varenicline, a generic version of Champix for smoking cessation, and Betahistine, a generic version of Serc for treating vertigo.
September 26, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sunshine Biopharma has expanded its product line with the launch of two new generic drugs, potentially increasing its market presence and revenue.
The launch of new generic drugs can enhance Sunshine Biopharma's market position and revenue potential. Varenicline and Betahistine address significant health issues, which may lead to increased demand and sales.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100